Reversible posterior encephalopathy syndrome in three cases

2021 ◽  
Vol 429 ◽  
pp. 119711
Author(s):  
Hassane Zobiri
Keyword(s):  
Posterior Encephalopathy ◽  
Reversible Posterior Encephalopathy Syndrome

scholarly journals CYCLOPHOSPHAMIDE FOR LUPUS NEPHRITIS CAUSING PRES (REVERSIBLE POSTERIOR ENCEPHALOPATHY SYNDROME): CASE REPORT

2019 ◽  
Author(s):  
ANDRÉ ADALBERTO PETRY ◽  
DEBORAH COLOMBO ◽  
MARIANA ANDRADE ◽  
JULIANA DELFINO ◽  
THIAGO ALBERTO FERNANDES GOMES DOS SANTOS ◽  
...  
Keyword(s):  
Case Report ◽  
Lupus Nephritis ◽  
Posterior Encephalopathy ◽  
Reversible Posterior Encephalopathy Syndrome

Reversible posterior encephalopathy syndrome associated with late onset postpartum eclampsia

2017 ◽  
Vol 1 (2) ◽  
pp. 65
Author(s):  
Akram Henein ◽  
Asma Alsalehi ◽  
Maged Saad ◽  
Neelam Suri ◽  
Nilay Chattergie
Keyword(s):  
Late Onset ◽  
Posterior Encephalopathy ◽  
Reversible Posterior Encephalopathy Syndrome

scholarly journals Reversible Posterior Encephalopathy Syndrome Secondary to Sunitinib

2014 ◽  
Vol 2014 ◽  
pp. 1-3 ◽  
Author(s):  
Ricardo Costa ◽  
Rubens Costa ◽  
Renata Costa ◽  
Gilberto Moura de Brito Junior ◽  
Henrique Queiroz Cartaxo ◽  
...  
Keyword(s):  
Growth Factor Receptor ◽  
Reversible Posterior Leukoencephalopathy Syndrome ◽  
Uncontrolled Hypertension ◽  
Cerebral White Matter ◽  
Vascular Endothelial ◽  
Posterior Leukoencephalopathy ◽  
Posterior Encephalopathy ◽  
Reversible Posterior Encephalopathy Syndrome ◽  
Antiangiogenic Drugs ◽  
Endothelial Growth Factor

Reversible posterior leukoencephalopathy syndrome (RPLS) is clinical radiologic condition associated with neurological symptoms and cerebral white matter edema. It has been associated with uncontrolled hypertension, eclampsia, immunosuppressants, and more recently the use of antiangiogenic drugs. Sunitinib is an inhibitor of the vascular endothelial growth factor receptor widely used in the treatment of metastatic renal cell carcinoma (RCC). We report a rare case of RPLS occurring on therapy with sunitinib in a patient with RCC. Our aim is to highlight the importance of considering RPLS as a diagnostic possibility and to hold sunitinib for RCC patients presenting with neurologic symptoms.

Reversible posterior encephalopathy syndrome in children with nephrotic syndrome

Nephrology ◽  
2015 ◽  
Vol 20 (11) ◽  
pp. 849-854 ◽  
Author(s):  
Juan Zhou ◽  
Helin Zheng ◽  
Xuefei Zhong ◽  
Daoqi Wu ◽  
Mo Wang ◽  
...  
Keyword(s):  
Nephrotic Syndrome ◽  
Posterior Encephalopathy ◽  
Reversible Posterior Encephalopathy Syndrome

Reversible posterior encephalopathy syndrome associated with bortezomib

2010 ◽  
Vol 40 (1) ◽  
pp. 69-71 ◽  
Author(s):  
E. Terwiel ◽  
R. Hanrahan ◽  
C. Lueck ◽  
J. D'Rozario
Keyword(s):  
Posterior Encephalopathy ◽  
Reversible Posterior Encephalopathy Syndrome

scholarly journals Evaluation of nine children with reversible posterior encephalopathy syndrome

2009 ◽  
Vol 57 (4) ◽  
pp. 475 ◽  
Author(s):  
Faruk Incecik ◽  
MOzlem Herguner ◽  
Sakir Altunbasak ◽  
Fatih Erbey ◽  
Goksel Leblebisatan
Keyword(s):  
Posterior Encephalopathy ◽  
Reversible Posterior Encephalopathy Syndrome
Sign in / Sign up

Export Citation Format

Share Document